Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
EO-2002 by Emmecell for Corneal Edema: Likelihood of Approval
EO-2002 is under clinical development by Emmecell and currently in Phase I for Corneal Edema. According to GlobalData, Phase I...